Strong Buy
Average AnalystStrong Buy
Top AnalystBearish
Stock Target AdvisorStrong Buy
Average UserUSD 17.84
-0.15 (-0.83)%
USD 1.83B
1.60M
USD 50.15(+181.13%)
Symbol | Name | Exchange | NTLA's Weight | Expense Ratio | Price(Change) | Market Cap |
---|---|---|---|---|---|---|
|
ARK Genomic Revolution UC.. | LSE | 4.80 % | 0.00 % | -0.01 (-0.22%) | USD2.96M |
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
The company had negative total cash flow in the most recent four quarters.
The company had negative total free cash flow in the most recent four quarters.
This stock has shown below median revenue growth in the previous 5 years compared to its sector
This stock has shown below median earnings growth in the previous 5 years compared to its sector